drugset / Trial / NCT03307590

Comparing Dexmedetomidine With Bupivacaine Versus Bupivacaine Alone for Caudal Block in Supra - Umbilical Surgeries

NCT03307590

Phase 2/3 Completed 24 enrolled Cairo University
RandomizedParallel-groupOpen-labelPrevention

Summary

dexmedetomidine is an alpha 2 adrenergic receptor agonist that is given either systemically or combined to local anesthetics during regional blocks. Investigators studied the combination of dexmedetomedine/bupivacaine versus bupivacaine alone for caudal blockage in pediatric patients undergoing supra - umbilical surgeries.

Timeline

Start
2017-10-01
Primary completion
2017-12-30
Completion
2017-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Bupivacaine Other / unclassified 1.25 ml Other
Comparator Dexmedetomidine Other / unclassified 1.5 ug/kg Other

Indications

No indication recorded.